X

Vous n'êtes pas connecté

Rubriques :

  - ZACKS.COM - All Stories - 11/Aug 22:55

Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +22.22% and -9.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 11/Aug 23:00

TELA Bio (TELA) delivered earnings and revenue surprises of -22.22% and -1.72%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

Cadiz (CDZI) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 13/Aug 22:35

Cadiz (CDZI) delivered earnings and revenue surprises of -22.22% and -1.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues...

Sorry! Image not available at this time

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 04/Aug 21:55

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +12.24% and -86.45%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 06/Aug 21:25

Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of -3.77% and -46.67%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 06/Aug 21:30

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -18.75% and -55.43%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 11/Aug 23:00

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -13.68% and -5.37%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 06/Aug 12:15

Entrada Therapeutics (TRDA) delivered earnings and revenue surprises of -20.93% and -78.02%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 12/Aug 19:00

BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 12/Aug 19:00

BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - 13:15

VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +43.48% and -31.00%, respectively, for the quarter ended June 2025. Do the...

Les derniers communiqués